Beijing Double-crane Pharmaceutical Acquires Shenzhou Pharmaceutical
This article was originally published in PharmAsia News
Guangdong Shenzhou Pharmaceutical, one of the few companies producing soft packaging for transfusion in South China, faces huge debts after establishing four advanced production lines for PVC soft packaging. Beijing Double-crane Pharmaceutical will acquire 90 percent stake of the cash-strapped company for a token 1 yuan; the purchase will double its soft packaging production capacity and improve current processes and bottom line. The acquisition of high-tech hardware and manufacturing facilities will strengthen Double-crane's position in South China and improve its nationwide production network. Double-crane will incorporate Shenzhou's management, production, purchase and allocation processes into its management model for maximum optimization. (Click here for more - Chinese Language)
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.